Upsides of investing in the IPO include diversified 1,600+ SKU portfolio, exports to 30+ countries, niche medical-device capabilities and use of proceeds for capacity expansion offering an attractive long-term growth potential.
Upsides of investing in the IPO include diversified 1,600+ SKU portfolio, exports to 30+ countries, niche medical-device capabilities and use of proceeds for capacity expansion offering an attractive long-term growth potential.